<p>Positive immunohistochemistry staining of CD31 was shown as brown part in each figure. Micro-vessel density (MVD) was counted at Section×200. Well-formed capillaries were observed in the tumors from NS group (A) and L-ES group (B). Isolated micro-vessels were shown in Bevacizumab group (C) and H-ES group (D). MVD was significantly decreased in H-ES group compared with that in NS group or L-ES group, and there is no significant difference between Bevacizumab group and H-ES group (E).Columns: mean value of each group, bars: ±SD. ***P<0.001, ** P<0.01, *P<0.05. ns: no significant difference.</p
<p>(A) and (B) show tumor vasculature visualized by immunohistochemistry of microdissected tumor sec...
A: ß3-integrin, therapy. B: ß3-integrin, control. C: CD31, therapy. D: CD31, control. E: Ki-67, ther...
Microvessel density of benign, borderline and malignant ovarian tumours was studied immunohistochemi...
<p>Positive immunohistochemistry staining of D2-40 was shown as brown part in each figure. Positive ...
<p>Positive immunohistochemistry staining of VEGF-C was shown as brown part in each figure. Expressi...
<p>Positive immunohistochemistry staining of VEGF-A was shown as brown part in each figure. Expressi...
<p>(A) Immunohistochemical staining with anti-CD31 antibody. The arrow indicates a representative mi...
<p>CT images of four groups showed that bilateral pleural effusion was visible in the mice treated w...
IntroductionThe use of bevacizumab combined with chemotherapy represents a recent advance in clinica...
<p>(A) a vehicle treated (upper row) tumor presenting a high microvessel density index (MDI (1/mm<su...
<p>A: Wound tissue in group 1 (implanted with untreated fibroblasts). B: Wound tissue in group 2 (im...
<p>A, The graph shows the changes of mean MVD in the control and treated tumors post treatment. Ther...
<p>(<b>A</b>) Blood vessel density in STSA-1 tumors The vascular density was measured in CD31-labele...
<p>Fluorescence images of tumors showed CD31-positive endothelial cells (red), type IV collagen-posi...
<p>(<b>A</b>) Representative images of CD31 positive microvessels and Ki-67 positive cells in tumor ...
<p>(A) and (B) show tumor vasculature visualized by immunohistochemistry of microdissected tumor sec...
A: ß3-integrin, therapy. B: ß3-integrin, control. C: CD31, therapy. D: CD31, control. E: Ki-67, ther...
Microvessel density of benign, borderline and malignant ovarian tumours was studied immunohistochemi...
<p>Positive immunohistochemistry staining of D2-40 was shown as brown part in each figure. Positive ...
<p>Positive immunohistochemistry staining of VEGF-C was shown as brown part in each figure. Expressi...
<p>Positive immunohistochemistry staining of VEGF-A was shown as brown part in each figure. Expressi...
<p>(A) Immunohistochemical staining with anti-CD31 antibody. The arrow indicates a representative mi...
<p>CT images of four groups showed that bilateral pleural effusion was visible in the mice treated w...
IntroductionThe use of bevacizumab combined with chemotherapy represents a recent advance in clinica...
<p>(A) a vehicle treated (upper row) tumor presenting a high microvessel density index (MDI (1/mm<su...
<p>A: Wound tissue in group 1 (implanted with untreated fibroblasts). B: Wound tissue in group 2 (im...
<p>A, The graph shows the changes of mean MVD in the control and treated tumors post treatment. Ther...
<p>(<b>A</b>) Blood vessel density in STSA-1 tumors The vascular density was measured in CD31-labele...
<p>Fluorescence images of tumors showed CD31-positive endothelial cells (red), type IV collagen-posi...
<p>(<b>A</b>) Representative images of CD31 positive microvessels and Ki-67 positive cells in tumor ...
<p>(A) and (B) show tumor vasculature visualized by immunohistochemistry of microdissected tumor sec...
A: ß3-integrin, therapy. B: ß3-integrin, control. C: CD31, therapy. D: CD31, control. E: Ki-67, ther...
Microvessel density of benign, borderline and malignant ovarian tumours was studied immunohistochemi...